Want to join the conversation?
$GILD 2Q15 Call: Revised 2015 outlook: product gross margin of 88–90%; R&D expenses of $2.8-3Bil, driven by cost efficiencies and clinical development activities, and faster-than-expected enrollment of HIV and HCV studies; SG&A expenses of $3-3.2Bil; tax rate of 17-18%. All other components of 2015 outlook remain unchanged.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!